Please use this identifier to cite or link to this item:
|Scopus||Web of Science®||Altmetric|
|Citation:||Current Infectious Disease Reports, 2011; 13(3):236-242|
|Abstract:||Clinical toxinology is a specialized area of clinical medicine focused on the pathophysiology, diagnosis, treatment, and prevention of diseases caused by animal, plant, and fungal toxins. This review focuses on recent developments in snakebite. Snakebite is newly recognized as a Neglected Tropical Disease by the World Health Organization (WHO), reflecting the large human and economic cost of this disease. New WHO guidelines on antivenom production are available. The methods of producing antivenom and dosing are changing as understanding of envenoming improves. Lower antivenom doses in some regions are delivering equal outcomes, but antivenom cannot fully treat all envenoming types. Early antivenom treatment may reduce local tissue damage in some types of snakebite.|
|Keywords:||Toxinology; venom; toxins; snake; snakebite; envenoming; antivenom; coagulopathy; paralysis; necrosis; renal failure; review|
|Rights:||© Springer Science+Business Media, LLC 2011|
|Appears in Collections:||Paediatrics publications|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.